Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009570147> ?p ?o ?g. }
- W2009570147 endingPage "907" @default.
- W2009570147 startingPage "900" @default.
- W2009570147 abstract "AimThis study evaluated long-term characteristics of chronic venous disease (CVD) progression and its correlation with the modification of specific risk factors.MethodsThe contralateral limb of 73 patients (95% women; mean age, 48 ± 12 years) undergoing varicose vein surgery was prospectively evaluated using physical and color duplex examination and classified by CEAP. After 5 years of follow-up, development of new sites of reflux among the contralateral, preoperatively asymptomatic limbs and modification of predisposing factors, including prolonged orthostatism, obesity, estrogen therapy (ET), multiparity, and elastic stockings use (ESU), were assessed. Data were analyzed with Pearson χ2, t test, binary logistic regression, and Spearman ρ.ResultsForty-eight new sites of reflux (superficial system, 37; perforators, 5; deep veins, 6) were revealed in 38 limbs (52%). CEAP scores significantly deteriorated: clinical, 2.2 ± 0.5 from 0.1 ± 0.03 (P < .01); anatomic, 3.8 ± 1.2 from 2.6 ± 2.5 (P < .05); disability, 1.9 ± 0.7 from 0 (P < .01); and severity, 7.9 ± 2.4 from 2.7 ± 2.2 (P < .01). Patient compliance to predisposing factor modification was low; no change was observed during follow-up (orthostatism, P = .9; obesity, P = 0.7; ET, P = .9; multiparity, P = .4; ESU, P = .3). CVD progression was significantly lower in patients who controlled orthostatism vs those who maintained orthostatism or initiated it (P < .001) and in patients who controlled preoperative obesity vs those who became obese or maintained obesity (P < .001). Non-ESU patients had a significantly higher incidence of CVD progression vs those who started ESU or continued during the study (P < .001). By binary logistic regression analysis, orthostatism (P = .002; B coefficient value [BCV] = 1.745), obesity (P = .009; BCV = 1.602), and ESU (P = .037; BCV = 0.947) were independent predictive factors for CVD progression, whereas multiparity (P = .174) and ET (P = .429) were not.ConclusionsIn about half of patients with unilateral varicosities, CVD developed in the contralateral initially asymptomatic limb in 5 years. CVD progression consisted of reflux development and clinical deterioration of the affected limbs. Obesity, orthostatism, and noncompliance with ESU were independent risk factors for CVD progression, but ET and multiparity were not. Maintenance of a normal body weight, limitation of prolonged orthostatism, and systematic ESU may be recommended in patients with CVD to limit future disease progression. This study evaluated long-term characteristics of chronic venous disease (CVD) progression and its correlation with the modification of specific risk factors. The contralateral limb of 73 patients (95% women; mean age, 48 ± 12 years) undergoing varicose vein surgery was prospectively evaluated using physical and color duplex examination and classified by CEAP. After 5 years of follow-up, development of new sites of reflux among the contralateral, preoperatively asymptomatic limbs and modification of predisposing factors, including prolonged orthostatism, obesity, estrogen therapy (ET), multiparity, and elastic stockings use (ESU), were assessed. Data were analyzed with Pearson χ2, t test, binary logistic regression, and Spearman ρ. Forty-eight new sites of reflux (superficial system, 37; perforators, 5; deep veins, 6) were revealed in 38 limbs (52%). CEAP scores significantly deteriorated: clinical, 2.2 ± 0.5 from 0.1 ± 0.03 (P < .01); anatomic, 3.8 ± 1.2 from 2.6 ± 2.5 (P < .05); disability, 1.9 ± 0.7 from 0 (P < .01); and severity, 7.9 ± 2.4 from 2.7 ± 2.2 (P < .01). Patient compliance to predisposing factor modification was low; no change was observed during follow-up (orthostatism, P = .9; obesity, P = 0.7; ET, P = .9; multiparity, P = .4; ESU, P = .3). CVD progression was significantly lower in patients who controlled orthostatism vs those who maintained orthostatism or initiated it (P < .001) and in patients who controlled preoperative obesity vs those who became obese or maintained obesity (P < .001). Non-ESU patients had a significantly higher incidence of CVD progression vs those who started ESU or continued during the study (P < .001). By binary logistic regression analysis, orthostatism (P = .002; B coefficient value [BCV] = 1.745), obesity (P = .009; BCV = 1.602), and ESU (P = .037; BCV = 0.947) were independent predictive factors for CVD progression, whereas multiparity (P = .174) and ET (P = .429) were not. In about half of patients with unilateral varicosities, CVD developed in the contralateral initially asymptomatic limb in 5 years. CVD progression consisted of reflux development and clinical deterioration of the affected limbs. Obesity, orthostatism, and noncompliance with ESU were independent risk factors for CVD progression, but ET and multiparity were not. Maintenance of a normal body weight, limitation of prolonged orthostatism, and systematic ESU may be recommended in patients with CVD to limit future disease progression." @default.
- W2009570147 created "2016-06-24" @default.
- W2009570147 creator A5014579164 @default.
- W2009570147 creator A5030760607 @default.
- W2009570147 creator A5040626094 @default.
- W2009570147 creator A5055787261 @default.
- W2009570147 creator A5063619995 @default.
- W2009570147 creator A5071268887 @default.
- W2009570147 creator A5085471167 @default.
- W2009570147 date "2010-04-01" @default.
- W2009570147 modified "2023-10-14" @default.
- W2009570147 title "Chronic venous disease progression and modification of predisposing factors" @default.
- W2009570147 cites W1975584082 @default.
- W2009570147 cites W1976533785 @default.
- W2009570147 cites W1977339917 @default.
- W2009570147 cites W1977843926 @default.
- W2009570147 cites W1981088832 @default.
- W2009570147 cites W1983845869 @default.
- W2009570147 cites W1984509837 @default.
- W2009570147 cites W1991475780 @default.
- W2009570147 cites W1997292034 @default.
- W2009570147 cites W2016472401 @default.
- W2009570147 cites W2024296782 @default.
- W2009570147 cites W2073437194 @default.
- W2009570147 cites W2078876887 @default.
- W2009570147 cites W2083315811 @default.
- W2009570147 cites W2092324872 @default.
- W2009570147 cites W2095294819 @default.
- W2009570147 cites W2116869293 @default.
- W2009570147 cites W2137496691 @default.
- W2009570147 cites W2151090403 @default.
- W2009570147 cites W2160404825 @default.
- W2009570147 cites W2400055742 @default.
- W2009570147 cites W2473647983 @default.
- W2009570147 cites W2598521832 @default.
- W2009570147 doi "https://doi.org/10.1016/j.jvs.2009.10.119" @default.
- W2009570147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20347686" @default.
- W2009570147 hasPublicationYear "2010" @default.
- W2009570147 type Work @default.
- W2009570147 sameAs 2009570147 @default.
- W2009570147 citedByCount "63" @default.
- W2009570147 countsByYear W20095701472012 @default.
- W2009570147 countsByYear W20095701472013 @default.
- W2009570147 countsByYear W20095701472014 @default.
- W2009570147 countsByYear W20095701472015 @default.
- W2009570147 countsByYear W20095701472016 @default.
- W2009570147 countsByYear W20095701472017 @default.
- W2009570147 countsByYear W20095701472018 @default.
- W2009570147 countsByYear W20095701472019 @default.
- W2009570147 countsByYear W20095701472020 @default.
- W2009570147 countsByYear W20095701472021 @default.
- W2009570147 countsByYear W20095701472022 @default.
- W2009570147 countsByYear W20095701472023 @default.
- W2009570147 crossrefType "journal-article" @default.
- W2009570147 hasAuthorship W2009570147A5014579164 @default.
- W2009570147 hasAuthorship W2009570147A5030760607 @default.
- W2009570147 hasAuthorship W2009570147A5040626094 @default.
- W2009570147 hasAuthorship W2009570147A5055787261 @default.
- W2009570147 hasAuthorship W2009570147A5063619995 @default.
- W2009570147 hasAuthorship W2009570147A5071268887 @default.
- W2009570147 hasAuthorship W2009570147A5085471167 @default.
- W2009570147 hasBestOaLocation W20095701471 @default.
- W2009570147 hasConcept C120665830 @default.
- W2009570147 hasConcept C121332964 @default.
- W2009570147 hasConcept C126322002 @default.
- W2009570147 hasConcept C141071460 @default.
- W2009570147 hasConcept C2777475103 @default.
- W2009570147 hasConcept C2777910003 @default.
- W2009570147 hasConcept C2779134260 @default.
- W2009570147 hasConcept C43270747 @default.
- W2009570147 hasConcept C50440223 @default.
- W2009570147 hasConcept C511355011 @default.
- W2009570147 hasConcept C61511704 @default.
- W2009570147 hasConcept C71924100 @default.
- W2009570147 hasConcept C90924648 @default.
- W2009570147 hasConceptScore W2009570147C120665830 @default.
- W2009570147 hasConceptScore W2009570147C121332964 @default.
- W2009570147 hasConceptScore W2009570147C126322002 @default.
- W2009570147 hasConceptScore W2009570147C141071460 @default.
- W2009570147 hasConceptScore W2009570147C2777475103 @default.
- W2009570147 hasConceptScore W2009570147C2777910003 @default.
- W2009570147 hasConceptScore W2009570147C2779134260 @default.
- W2009570147 hasConceptScore W2009570147C43270747 @default.
- W2009570147 hasConceptScore W2009570147C50440223 @default.
- W2009570147 hasConceptScore W2009570147C511355011 @default.
- W2009570147 hasConceptScore W2009570147C61511704 @default.
- W2009570147 hasConceptScore W2009570147C71924100 @default.
- W2009570147 hasConceptScore W2009570147C90924648 @default.
- W2009570147 hasIssue "4" @default.
- W2009570147 hasLocation W20095701471 @default.
- W2009570147 hasLocation W20095701472 @default.
- W2009570147 hasOpenAccess W2009570147 @default.
- W2009570147 hasPrimaryLocation W20095701471 @default.
- W2009570147 hasRelatedWork W175582500 @default.
- W2009570147 hasRelatedWork W1969001704 @default.
- W2009570147 hasRelatedWork W2009307687 @default.
- W2009570147 hasRelatedWork W2042246149 @default.
- W2009570147 hasRelatedWork W2088453730 @default.